Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study.
New Microparticle Secondary Progressive MS Therapy Dosing Tested In Australian Clinical Trial
Impact of multiple sclerosis relapses on progression diminishes with time.
Multiple sclerosis: clinical features and MRI findings in Northern China.
Viruses and Multiple Sclerosis.
The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?
Decreased serum levels of nucleolin protein fragment, as analyzed by bead-based proteomic technology, in multiple sclerosis patients compared to controls.
Multiple Sclerosis: A Disease of Affluence?.
[Clinical study of optic neuritis combined with viral hepatitis].
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]
Oral laquinimod for multiple sclerosis.
Immune-mediated disorders among women carriers of fragile X premutation alleles.
Fingolimod Therapy and Macular Hemorrhage.
Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis.
The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma.
Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
[von Willebrand factor and adhesion molecules in patients with multiple sclerosis.]
Reducing falls and improving mobility in multiple sclerosis.
Missed epidemics and missing links: international birth cohort trends in multiple sclerosis.
Synthesis and biological evaluation of tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R(8)ERY.
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab.
Whole-Brain In-vivo Measurements of the Axonal G-Ratio in a Group of 37 Healthy Volunteers.
Pages
« first
‹ previous
…
272
273
274
275
276
277
278
279
280
…
next ›
last »